Fractyl Health, Inc. Cost of Revenue
Fractyl Health, Inc. (GUTS) reported Cost of Revenue of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-03-24
- Fractyl Health, Inc. cost of revenue for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Fractyl Health, Inc. cost of revenue for the quarter ending 2024-09-30 was $7.00K, a 72.00% decline year-over-year.
- Fractyl Health, Inc. cost of revenue for the quarter ending 2024-06-30 was $24.00K, a 48.94% decline year-over-year.
- Fractyl Health, Inc. cost of revenue for the quarter ending 2024-03-31 was $19.00K, a 533.33% increase year-over-year.
- Fractyl Health, Inc. cost of revenue for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Fractyl Health, Inc. cost of revenue for fiscal 2024 was $50.00K, a 35.06% decline from fiscal 2023.
- Fractyl Health, Inc. cost of revenue for fiscal 2023 was $77.00K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-24 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $7.00K derived: sum of 2 quarters · filed 2026-03-24 | $31.00K derived: sum of 3 quarters · filed 2026-03-24 | $50.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $7.00K 10-Q · filed 2025-11-12 | $31.00K derived: sum of 2 quarters · filed 2025-11-12 | $50.00K 10-Q · filed 2025-11-12 | $52.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $24.00K 10-Q · filed 2025-08-12 | $43.00K 10-Q · filed 2025-08-12 | $45.00K derived: sum of 3 quarters · filed 2025-08-12 | $70.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $19.00K 10-Q · filed 2025-05-13 | $21.00K derived: sum of 2 quarters · filed 2025-05-13 | $46.00K derived: sum of 3 quarters · filed 2025-05-13 | $93.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $27.00K derived: sum of 2 quarters · filed 2025-03-03 | $74.00K derived: sum of 3 quarters · filed 2025-03-03 | $77.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $25.00K 10-Q · filed 2024-11-12 | $72.00K derived: sum of 2 quarters · filed 2024-11-12 | $75.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $47.00K 10-Q · filed 2024-08-14 | $50.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $3.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |